Cancer Gene Therapy
Precision Therapeutics Announces New Tumor Profiling Product to Augment Utility of ChemoFx(R) and Further Personalize Cancer Treatment
Published in Gene Therapy Weekly, April 21st, 2011
2011 APR 21 -- Precision Therapeutics, Inc. announced that the launch of a new product line, BioSpeciFx®, will help further the personalization of cancer treatments. BioSpeciFx® is composed of carefully selected sets of well validated and clinically useful biomarker tests that identify critical molecular targets within a patient's cell. By using the information generated by BioSpeciFx® in combination with Precision's sophisticated drug response marker ChemoFx®, physicians may gain a more complete understanding of a patient's tumor.
When combined, both products offer a complementary sum of information which will enable physicians to look...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-04-21)
More Articles from Gene Therapy Weekly
- Small Interference RNAs (siRNAs)
Data on Small Interference RNAs (siRNAs) Reported by Researchers at University of Maryland - Endometriosis
New Endometriosis Study Findings Have Been Reported by Scientists at University of Athens - Small Interference RNAs (siRNAs)
New Small Interference RNAs (siRNAs) Study Findings Have Been Reported from Temple University - Stem Cell Research
New Stem Cell Research Data Have Been Reported by W.S. Lian and Co-Authors - Viral Vaccines
New Viral Vaccines Findings from University of Utah Described - Gene Therapy
Reports Outline Gene Therapy Study Results from F.X. Zhu et al - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
